You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre, randomised controlled trial

Article metrics

Article menu

Download PDFPDF

XML
Intensive care
Protocol
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre, randomised controlled trial

 

Online download statistics by month:

Online download statistics by month: January 2019 to April 2024

AbstractFullPdf
Jan 201935735161
Feb 201914513555
Mar 201911010369
Apr 201914413061
May 2019958955
Jun 201912112049
Jul 201910210126
Aug 201914413954
Oct 201915013657
Nov 2019958336
Dec 201912311652
Jan 202015215169
Feb 202020719666
Mar 202012711947
May 20209996118
Jun 2020726780
Jul 2020847745
Aug 2020888752
Sep 20201099654
Oct 202015414777
Nov 202019017998
Dec 202017216673
Jan 202113412249
Feb 20211009638
Mar 202113713665
Apr 202119318173
May 2021938354
Jun 2021909145
Jul 202111110950
Aug 2021666638
Sep 2021847950
Oct 20211029565
Nov 2021878261
Dec 2021787539
Jan 202211912149
Feb 202212012072
Mar 202216016557
Apr 202216115488
May 2022979152
Jun 2022756938
Jul 202210710353
Aug 202212712153
Sep 2022968452
Oct 2022979551
Nov 20221069255
Dec 2022787832
Jan 2023808049
Feb 202311611846
Mar 202316215567
Apr 202315314987
May 202317016569
Jun 202311811936
Jul 202311411134
Aug 202315614648
Sep 20231009751
Oct 202313012749
Nov 202310110030
Dec 2023929327
Jan 2024272417
Feb 202412810240
Mar 20241159972
Apr 2024817621
Total750171533376